glucagon



glucagon

H1HH1S2SS2Q3QQ3G4GG4T5TT5F6FF6T7TT7S8SS8D9DD9Y10YY10S11SS11K12KK12Y13YY13L14LL14D15DD15S16SS16R17RR17R18RR18A19AA19Q20QQ20D21DD21F22FF22V23VV23Q24QQ24W25WW25L26LL26M27MM27N28NN28T29TT29

SMILES None
InChIKey MASNOZXLGMXCHN-ZLPAWPGGSA-N
Sequence HSQGTFTSDYSKYLDSRRAQDFVQWLMNT

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections

Structure pdb 8JRV 7D68 6LMK 6LML
Ligand site mutations GLP-1 glucagon

Bioactivities

glucagon

H1HH1S2SS2Q3QQ3G4GG4T5TT5F6FF6T7TT7S8SS8D9DD9Y10YY10S11SS11K12KK12Y13YY13L14LL14D15DD15S16SS16R17RR17R18RR18A19AA19Q20QQ20D21DD21F22FF22V23VV23Q24QQ24W25WW25L26LL26M27MM27N28NN28T29TT29

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug Yes

Distribution across phases (no. indications)

Phase I 0
Phase II 1
Phase III 0
Phase IV 2

Database connections

Structure pdb 8JRV 7D68 6LMK 6LML
Ligand site mutations GLP-1 glucagon

Sankey plot

Drug Information